CONVERTIBLE NOTE PURCHASE AGREEMENTConvertible Note Purchase Agreement • November 23rd, 2021 • FS Development Corp. II • Pharmaceutical preparations • Delaware
This Convertible Note Purchase Agreement (this “Agreement”), dated as of November 15, 2021, is entered into among Pardes Biosciences, Inc., a Delaware corporation (the “Company”), and the persons and entities (each individually a “Purchaser,” and collectively, the “Purchasers”) named on the Schedule of Purchasers attached hereto (the “Schedule of Purchasers”).
